OSI oncology business
Executive Summary
Former Pharmacia Group VP-Global Prescription Business Gabriel Leung named OSI oncology president. Leung's initial responsibilities will include re-launches for Novantrone (licensed from Amgen) and Gelclair (acquired through Cell Pathways acquisition) (1"The Pink Sheet" May 19, p. 7)...
You may also be interested in...
OSI Confident On Tarceva After Iressa Approval; Brain Cancer Is Back-Up Plan
OSI Pharmaceuticals is confident about Tarceva's prospects for FDA clearance based on the recent Subpart H approval of AstraZeneca's Iressa
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.